Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.
| Composition | : | Betamethasone (0.1% w/w); Neomycin Sulphate (0.5% w/w) |
| Indication | : | For the treatment of allergic dermatitis and other inflammatory skin disease when complicated by infection caused by organisms susceptible to neomycin including contact dermatitis,neurodermatitis, atopic dermatitis (allergic aczema), non-specific anogenital pruritus and seborrheic dermatitis. |
| Packaging | : | 20g tub, 15g tube |
| Registration No. | : | MAL19860243AZ |